Stay updated on Amifampridine in MuSK-MG Clinical Trial
Sign up to get notified when there's something new on the Amifampridine in MuSK-MG Clinical Trial page.

Latest updates to the Amifampridine in MuSK-MG Clinical Trial page
- Check6 days agoChange DetectedRevision history updated: added v3.3.2 and removed v3.2.0.SummaryDifference0.1%

- Check13 days agoChange DetectedThe government funding/operating status notice at the top of the page has been removed.SummaryDifference0.4%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedMinor UI and layout updates observed on the Study Details page, with no changes to core content such as the study title, eligibility criteria, or primary outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check56 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference4%

- Check63 days agoChange DetectedAdded a new version label (v3.1.0) and removed several safety-focused topics (drug safety, counterfeit drugs, pharmaceutical preparations, substandard drugs), indicating a shift in page scope away from those subjects.SummaryDifference0.5%

- Check77 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1, indicating a new release; the 'Back to Top' navigation element has been removed, a minor UI change with no substantive content updates.SummaryDifference0.2%

Stay in the know with updates to Amifampridine in MuSK-MG Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amifampridine in MuSK-MG Clinical Trial page.